ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

DRCCA Staff Boom To 145, Still Growing, Still Looking for People

November 25, 1983

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

American Cancer Society Publishes CT Screening Guidelines for Lung Cancer

January 11, 2013

In Brief: Cooper Says HEW May Stop Taking New Construction grants; Cancer Act Does Not Give Him That Right

May 2, 1975